The abstract is read at the publisher; the summary is JClub's.
Activated hepatic stellate cells in chronic liver disease remodel liver-resident CD8+ T cells, increasing CD103+ scar-localized cells while impairing antigen-dependent effector function.
- Why it matters: Chronic liver disease alters the liver’s immune niche, but how fibrosis reshapes human liver-resident CD8+ T cell differentiation, positioning, and function is unclear.
- What they did: They show that CD103-expressing liver-resident CD8+ T cells rise with fibrosis severity and localize to collagen-rich scar tissue, with HSC-derived and matrix-retained TGFβ promoting a residency program.
- The result: Despite higher abundance, CLD-associated liver-resident CD8+ T cells display T cell dysfunction signatures and inhibitory receptor upregulation, with partial functional restoration after PD-L1/PD-L2 blockade.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.